Platelet-treated tumor cells show downregulated E-cadherin levels (55) and upregulated expression of mesenchymal markers such as Snail, vimentin, fibronectin, plasminogen activator inhibitor 1, and matrix metalloproteinase (MMP)-9. This evidence concerns the gene MMP9 and neoplasm.